Clinical Trial Update: A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD) [Phase 2]

View source ↗

Summary

A multicenter Phase 2 proof-of-concept trial of intravitreal AL-78898A in geographic atrophy due to age-related macular degeneration was terminated, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• AL-78898A

Snippet

Sponsor: Alcon Research | Conditions: Geographic Atrophy | Phase 2 | Status: TERMINATED | Results posted: 2014-01-20